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INVITED SPEAKERS
Utility Of Nitric Oxide And Hydrogen Sulﬁde-Releas-
ing Chimeras As Anticancer Agents
Khosrow Kashﬁ
City University of New York Medical School, New York, USA
Background: Aspirin is chemopreventive but has signiﬁcant side
effects. We developed NOSH-aspirin a safer, nitric oxide and
hydrogen sulﬁde releasing hybrid.
Aim: Here we report on NOSH-aspirin as an anti-inﬂammatory
and its effects on human cancer cell kinetics and various cancer
xenografts.
Methods: Anti-inﬂammatory: Carageenan rat paw edema model.
Cancer cell lines: Colon, HT-29, HCT 15, SW 480; breast, MCF-7,
MDA-MB-231; pancreas, MIA PaCa2, BxPC3. Normal cell lines:
human mammary, HMEpC; pancreatic epithelial, ACBRI 515. Xeno-
grafts: nude mice implanted with HT-29, MDA-MB-231, MIA PaCa2
cells, were treated with NOSH-aspirin (100 mg/kg/d) or vehicle.
After 3 weeks, mice were sacriﬁced, tumors excised, weighed, and
ﬁxed for IHC studies.
Results: NOSH-aspirin signiﬁcantly reduced paw edema as func-
tion of time. NOSH-aspirin’s IC50 in nM at 24 h for cell growth
inhibition ranged from 50±2 to 250±10 in the cancer cell lines and
about 400-fold higher in the normal cell lines. The cell growth
inhibitory effects were due to a dose-dependent induction of
apoptosis and cell cycle arrest (G0/G1), leading to reductions in
cell proliferation. In xenografts, NOSH-aspirin had no effect on the
weight of the mice. Tumor volume was reduced as a function of
treatment time. At sacriﬁce, tumor mass reductions were colon:
89%, P¼0.005; breast: 91%, P¼0.006; pancreas: 75%, P¼0.0031.
Growth inhibition was due to reduced proliferation (decreased
PCNA expression), and induction of apoptosis (increased TUNEL
positive cells).
Conclusions: NOSH-aspirin is a potent anti-inﬂammatory, prefer-
entially affecting cancer cells and targets parameters important in
determining cellular mass.
http://dx.doi.org/10.1016/j.redox.2015.09.030
Antitumoral Activity Of Nitric Oxide-Releasing
Compounds
Magdalena Klink, Michal Kielbik, Izabela Szulc Kielbik,
Patrycja Przygodzka, Zoﬁa Sulowska
Institute of Medical Biology, Polish Academy of Sciences, Lodz, Poland
Background: Despite signiﬁcant improvements in the conven-
tional anti-ovarian cancer therapies, tumor cell resistance to
various cytostatic drugs remains a relevant problem. Therefore,
the new cancer treatment strategies are being developed. Among
many agents that have been studied for their potential anti-cancer
activity, the most promising are the nitric oxide (NO) donors-
syntethic compounds that release NO in vivo and/or in vitro.
Aim: We have evaluated the effect of NO donors on the SK-OV-3
and OVCAR-3 ovarian cancer cell lines. We assessed some of the
cancer cells’ speciﬁc features: the uncontrolled proliferation, over-
activation of particular signaling proteins, high resistance to
therapeutics and elevated expression and secretion of invasive-
ness/metastatic factors.
Methods: Two members of NONOates family were used: SPER/NO
and DETA/NO. Cancer cell lines were cultured with different
concentrations of NO donors. The cytotoxic, pro-apoptotic activity
of NO donors and their impact on the phosphorylation status of
STAT-3 and AKT in cells were determined. The expression of VEGF-
A, MMPs and TGF-β was also evaluated.
Results: NO donors inhibited ovarian cancer cells growth making
them also more susceptible to the cisplatin cytotoxic activity. More-
over, both NO donors induced apoptosis of cells and decreased activity
of signaling proteins (STAT3 and AKT). Similarly, SPER/NO and DETA/
NO lowered the secretion of pro-metastatic factors, responsible for
cancer cells invasiveness.
Conclusions: The obtained results show that both NO donors
demonstrated a wide range of action on both ovarian cancer cell
lines. Therefore, they have a high potential of being a supporting
compounds in the cancer therapies.
http://dx.doi.org/10.1016/j.redox.2015.09.031
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Hepatocellular carcinoma develops in cirrhotic liver. The nitric
oxide (NO) synthase type III (NOS-3) overexpression induces cell
death in hepatoma cells. The study developed gene therapy
designed to speciﬁcally overexpress NOS-3 in cultured hepatoma
cells, and in tumors derived from orthotopically implanted tumor
cells in ﬁbrotic livers. Liver ﬁbrosis was induced by CCl4 admin-
istration in mice. Hepa 1-6 cells were used for in vitro and in vivo
experiments. The ﬁrst generation adenovirus was designed to
overexpress NOS-3 (or GFP) and luciferase cDNA under the
regulation of murine alpha-fetoprotein (AFP) and Rous Sarcoma
Virus (RSV) promoters, respectively. Both adenoviruses were
administered through the tail vein two weeks after orthotopic
tumor cell implantation. AFP-NOS-3/RSV-Luciferase increased
oxidative-related DNA damage, p53, CD95/CD95L expression and
caspase-8 activity in cultured Hepa 1-6 cells. The increased
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expression of CD95/CD95L and caspase-8 activity was abolished by
L-NAME or p53 siRNA. The tail vein infusion of AFP-NOS- 3/RSV-
Luciferase adenovirus increased cell death markers, and
reduced cell proliferation of established tumors in ﬁbrotic livers.
The increase of oxidative/nitrosative stress induced by NOS-3
overexpression induced DNA damage, p53, CD95/CD95L expres-
sion and cell death in hepatocellular carcinoma cells. The effec-
tiveness of the gene therapy has been demonstrated in vitro and
in vivo.
http://dx.doi.org/10.1016/j.redox.2015.09.032
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NOSH-Aspirin Inhibits Colon Cancer Cell Growth:
Effects Of Positional Isomerism
Federica Vannini, Ravinder Kodela, Mitali Chattopadhyay,
Khosrow Kashﬁ
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Davis School of Biomedical Education, City University of New York
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Background: NOSH-aspirin, a novel hybrid that releases nitric
oxide (NO) and hydrogen sulﬁde (H2S) was designed to overcome
the potential side effects of aspirin.
Aim: We compared the cell growth inhibitory properties of ortho-,
meta-, and para-NOSH-aspirins. Effects of electron donating/with-
drawing groups on the stability and biological activity of these
novel compounds were also evaluated.
Methods: Cell line: HT-29 (Cyclooxygenase, COX-1 & -2 expres-
sing) and HCT 15 (COX null) human colon adenocarcimoa; Cell
growth: MTT; Cell cycle phase distribution: Flow cytometry;
Apoptosis: subdiploid (sub-G0/G1) peak in DNA content histo-
grams; Proliferation: PCNA; ROS: measured hydrogen peroxide
and super oxide by ﬂow cytometry using DCFDA and DHE dyes.
Results: The IC50s for growth inhibition in µM at 24 h were, HT-29:
ortho-NOSH-ASA (0.04±0.011), meta-NOSH-ASA (0.24±0.11), para-
NOSH-ASA (0.46±0.17); signiﬁcance between the groups were: o vs
m P40.05, o vs p Po0.05, m vs p P40.05; HCT 15: ortho-NOSH-ASA
(0.062±0.006), meta-NOSH-ASA (0.092±0.004), para-NOSH-ASA (0.37
±0.04); signiﬁcance between the groups were: o vs m Po0.01, o vs p
Po0.001, m vs p Po0.001. Electron donating/withdrawing groups
signiﬁcantly affected these IC50s. All positional isomers qualitatively
had similar effects on proliferation, apoptosis, and caused G0/G1 cell
cycle arrest in both colon cancer cell lines. The underlying mechanism
for these observations appeared to be mediated through ROS, as
pretreatment of the cells with N-acetylcysteine, partially blocked these
effects.
Conclusions: Positional isomerism affects the potency of NOSH-
aspirin. The effects appear to be COX independent.
http://dx.doi.org/10.1016/j.redox.2015.09.033
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Nitric Oxide And Oxygen: Actions And Interactions In
Health And Disease
Professor Sir Salvador Moncada
Director of Cancer Sciences, University of Manchester, Wolfson
Molecular Imaging Centre, UK
Nitric oxide (NO) inhibits cell respiration reversibly and in
competition with O2 through the inhibition of the mitochondrial
cytochrome c oxidase (Complex IV). At concentrations lower than
those required to inhibit respiration, endogenous NO enhances the
reduction of the electron transport chain, thus enabling cells to
maintain their O2 consumption. This however facilitates the
release of superoxide anion, which initiates the transcriptional
activation of NF-kB as an early signal of a stress response. Through
free radical formation, long-term inhibition of mitochondrial
respiration by NO leads to persistent inhibition of Complex I. This
is dependent on the S-nitrosylation of a speciﬁc thiol in the active
form of this protein. S-nitrosylation of Complex I might indicate
the early stages of a pathological process.
Inhibition of mitochondrial respiration by low concentrations
of NO at critical O2 concentrations also leads to prevention of the
stabilization of hypoxia-inducible factor-1α (HIF-1α) due to the
redistribution of O2 towards non-respiratory O2-dependent tar-
gets. This prevents the cell from registering a state of hypoxia at
low O2 concentrations. On the other hand, at higher concentra-
tions such as those generated in certain forms of cancer, NO
increases the expression of HIF-1α by an action most probably
involving a free radical mechanism.
It is likely that the interactions between oxygen and NO, either
at the mitochondria or in the cell in general, play a role in the
initiation and development of neoplastic transformation and
spreading. The ways in which these interactions operate remain
unclear and are likely to vary from cancer to cancer.
http://dx.doi.org/10.1016/j.redox.2015.09.034
V. Rapozzi et al. / Redox Biology 5 (2015) 413–423 421
